Skip to content
by Legal Desire
7 August 2025

Sidley Advises BDT & MSD Partners on Their AU$1.6 Billion Strategic Investment in DBG Health

Advising firms

Deal team

16 lawyers named
LawyerFirmSeniorityPracticeOffice
David Perkins Lead Sidley Not stated M&A and Private Equity Not stated
Rob Garritano Lead Sidley Not stated M&A and Private Equity Not stated
Louis Jennings Sidley Not stated M&A and Private Equity Not stated
Adi Milstein Sidley Not stated M&A and Private Equity Not stated
Noam Waltuch Sidley Not stated Tax Not stated
Rachel Kleinberg Sidley Not stated Tax Not stated
Andy Lau Sidley Not stated Tax Not stated
Diane McEnroe Sidley Not stated Food, Drug and Medical Device Not stated
Deeona Gaskin Sidley Not stated Food, Drug and Medical Device Not stated
Susan Stolzer Sidley Not stated Food, Drug and Medical Device Not stated
Kelly Cho Sidley Not stated Food, Drug and Medical Device Not stated
Chad Ehrenkranz Sidley Not stated Healthcare Not stated
George Maliha M.D. Sidley Not stated Healthcare Not stated
Jenna Hoskison Sidley Not stated Healthcare Not stated
Vadim Brusser Sidley Not stated Antitrust and Competition Not stated
Mary Marks Sidley Not stated Antitrust and Competition Not stated

Stated terms

Stated value
AUD 1.60bn (AU$1.6 billion)
What the figure measures
Total transaction value
Client
BDT & MSD PartnersInvestor
Counterparties
DBG Health (Target)